Stock comparison
Novartis AG is 54.0x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($295.04 B vs $5.47 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 54.0x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($295.04 B vs $5.47 B).
Market value leader
NVS
Novartis AG is 54.0x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($295.04 B vs $5.47 B).
| Metric | DNTH | NVS |
|---|---|---|
| Market cap | $5.47 B | $295.04 B |
| US-listed rank | #1352 | #46 |
| Revenue (latest FY) | $2.04M | - |
| Net income (latest FY) | -$162.34M | - |
| Net margin | -7973.3% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 624 | 981 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 54.0x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($295.04 B vs $5.47 B).
Full pages: Dianthus Therapeutics, Inc. /DE/ and Novartis AG, or browse the full rankings.